IDHDP Resources
Best practice in drug interventions: Prisons
Prisons are one of the most important settings to provide interventions aimed at drug users, both in terms of treatment and harm reduction.
Prisons are one of the most important settings to provide interventions aimed at drug users, both in terms of treatment and harm reduction.
Best practice in drug interventions: Prescription medicines
The EMCDDA defines misuse of medicines the use of a psychoactive medicine with or without a prescription from an appropriate practitioner, clearly outside of accepted medical practice or guidelines, for either self-medication, recreational or enhancement purposes, including in the context of poly drug use.
The EMCDDA defines misuse of medicines the use of a psychoactive medicine with or without a prescription from an appropriate practitioner, clearly outside of accepted medical practice or guidelines, for either self-medication, recreational or enhancement purposes, including in the context of poly drug use.
Opioid painkiller dependency (OPD) An overview
A report written for the All-Party Parliamentary Group on Prescribed Medicine Dependency.
A report written for the All-Party Parliamentary Group on Prescribed Medicine Dependency.
Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
When people who are receiving methadone maintenance treatment for opioid dependence are incarcerated in prison or jail, most US correctional facilities discontinue their methadone treatment. This discontinuation can cause uncomfortable symptoms of withdrawal and renders prisoners susceptible to relapse and overdose on release.
When people who are receiving methadone maintenance treatment for opioid dependence are incarcerated in prison or jail, most US correctional facilities discontinue their methadone treatment. This discontinuation can cause uncomfortable symptoms of withdrawal and renders prisoners susceptible to relapse and overdose on release.
THE ELEPHANT IN THE ROOM: DRUGS AND HUMAN RIGHTS IN LATIN AMERICA
This article seeks to expose the tensions between the enforcement of drug laws and human rights.
This article seeks to expose the tensions between the enforcement of drug laws and human rights.
The Global Fund to Fight AIDS, Tuberculosis and Malaria’s investments in harm reduction through the rounds-based funding model (2002–2014)
Harm reduction is an evidence-based, effective response to HIV transmission and other harms faced by people who inject drugs, and is explicitly supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria. This study represents an updated, comprehensive assessment of Global Fund investments in harm reduction from 2002 to 2014.
Harm reduction is an evidence-based, effective response to HIV transmission and other harms faced by people who inject drugs, and is explicitly supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria. This study represents an updated, comprehensive assessment of Global Fund investments in harm reduction from 2002 to 2014.
Drug and Alcohol Review: New psychoactive substances
In recent years, there has been a notable increase in the use of new psychoactive substances (NPS) which have been marketed as “legal highs”. This virtual issue draws together recent papers from Drug and Alcohol Review on the topic of NPS, including the fluidity of the market for these substances, the extent of their use and the potential consequences of their use.
In recent years, there has been a notable increase in the use of new psychoactive substances (NPS) which have been marketed as “legal highs”. This virtual issue draws together recent papers from Drug and Alcohol Review on the topic of NPS, including the fluidity of the market for these substances, the extent of their use and the potential consequences of their use.
Special Report: Harm Reduction and the Global HIV Epidemic
A new report from amfAR, assesses the state of harm reduction worldwide by focusing on the steps that five sample countries; Kenya, Kyrgyzstan, Nigeria, Ukraine, and Vietnam, have, or have not, taken to address the HIV epidemic among people who inject drugs (PWID).
A new report from amfAR, assesses the state of harm reduction worldwide by focusing on the steps that five sample countries; Kenya, Kyrgyzstan, Nigeria, Ukraine, and Vietnam, have, or have not, taken to address the HIV epidemic among people who inject drugs (PWID).
Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first OSTPP in Kabul, Afghanistan
This report aims to evaluate an Opioid Substitution Therapy Pilot Program (OSTPP) in Kabul, particularly to describe characteristics of the participants and identify factors associated with client retention.
This report aims to evaluate an Opioid Substitution Therapy Pilot Program (OSTPP) in Kabul, particularly to describe characteristics of the participants and identify factors associated with client retention.
Injecting drug users in England, Wales and Northern Ireland in 2014
Slideshow information from Public Health England and the National Infection Service.
Slideshow information from Public Health England and the National Infection Service.
